$125.62 1.35 (1.09%)
18:30 EDT ZTS Stock Quote Delayed 15 Minutes
Previous Close $125.62
Market Cap 60.78B
PE Ratio 63.13
Volume (Avg. Vol.) 2.59M
Day's Range 124.64 - 126.14
52-Week Range 78.90 - 130.08
Dividend & Yield 0.38 (0.30%)
ZTS Stock Predictions, Articles, and Zoetis News
- From InvestorPlace
- From the Web
The grades of 10 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Investors and analysts are raising their eyebrows over some strange goings on at Valeant Pharmaceuticals, leading to our bear call on VRX stock
During these times it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 41 trades
It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider
During these times it pays to stay on top of the latest profit opportunities. Today's blog post should is a great place to start with our updated rankings
In this low interest rate environment, dividends are still looking great. Here is a list of 44 dividend stocks set for payouts this quarter
Among the leading companies moving to make shareholders happy last week was a mega-cap biotechnology giant, a mammoth defense and aerospace contractor, the biggest drug retailer in the world and a Big Pharma behemoth.
Today's blog post is a great place to start looking for those stock we have listed to both buy and sell based on the Portfolio Grader model.
Zoetis is a dominant market leader with decided scale advantages over its peers, operating in an industry with clear macro tailwinds. ZTS stock is a good buy at this level.
I want to clue you in on one of the equities I have a position in my Trader's Advantage service.
The grades of 10 pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
Dividend stocks in just about every sector thrilled investors with meaningful payout raises in Q4. Here's a look at 45 of the biggest blue chips to up the ante.
The central bank’s “patience” stance when it comes to future interest rate hikes was a present to the bulls, and the result was a week of pre-holiday stock market revelry. Here are 13 stocks increasing dividends.
Zoetis stock likely has more upside to come now that activist investor Bill Ackman has put it in play by building a $2 billion stake.
From Seeking Alpha
From Simply Wall St
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-zts/zoetis/news/did-business-growth-power-zoetiss-nysezts-share-price-gain-of-235/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!